FdaApplication
ANDA 212975
Identifiers
- fda_app_no: ANDA212975
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2025-04-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMATINIB MESYLATE | IMATINIB MESYLATE | EQ 100MG BASE | TABLET;ORAL |
| IMATINIB MESYLATE | IMATINIB MESYLATE | EQ 400MG BASE | TABLET;ORAL |
2 products